ERIN ERBSKORN: Open Payments
NPI 1194495390 · GAINESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 36 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $409 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 8 | $174 |
| ABBVIE INC. | 7 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $82 |
| Lilly USA, LLC | 4 | $70 |
| Exact Sciences Corporation | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Novo Nordisk Inc | 2 | $31 |
| Lundbeck LLC | 1 | $24 |
| Boston Scientific Corporation | 1 | $16 |
Products named: VOQUEZNA, VRAYLAR, CAPLYTA, MOUNJARO, The Cologuard Plus Collection Kit, AIRSUPRA, Ozempic, VYEPTI.
Industry payments across TX — which companies pay providers there.
